Congenital complete atrio-ventricular block;Bloc auriculo-ventriculaire complet congénital

Archives des Maladies du Coeur et des Vaisseaux

Volumn 97, Issue 10, 2004, Pages 994-999

  Villain, E ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MATERNAL ANTIBODY;

ACTIVITY CONTROLLED HEART RATE; ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR CONDUCTION; CHILD; COMPLETE HEART BLOCK; CONGESTIVE CARDIOMYOPATHY; FETUS DISEASE; HEART ATRIUM PACING; HEART FAILURE; HEART MUSCLE CONDUCTION DISTURBANCE; HEART MUSCLE FIBROSIS; HEART PACING; HEART RATE; HEART VENTRICLE PACING; HIGH RISK PATIENT; HUMAN; IMMUNOPATHOLOGY; INFECTION; MYOCARDITIS; PASSIVE IMMUNIZATION; PLACENTAL TRANSFER; RARE DISEASE; REVIEW; SUDDEN DEATH; SYNCOPE; TREATMENT INDICATION; VEIN THROMBOSIS;

AGE FACTORS; BODY WEIGHT; CHILD; CHILD, PRESCHOOL; HEART BLOCK; HEART RATE; HUMANS; INFANT; INFANT, NEWBORN; PACEMAKER, ARTIFICIAL;

EID: 7644239277     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Costedoat-Chalumeau N, Amoura Z, Le Thi Hong D et al. Lupus néonatal. Rev Med Int 2003; 24: 659-71.
2. Anderson RH, Ho SY. The morphologic substrates for paediatric arrhythmias. Cardiol Young 1991; 1: 159-76.
3. Miranda ME, Tseng CE, Rashbaum W et al. Accessibility of SSA/Ro and SSB/La antigens to maternal autoantibodies in apoptotic human fetal cardiac myocytes. J Immunol 1998; 161: 5061-9.
4. Clancy RM, Askanase AD, Kapur RP et al. Transdifferentiation of cardiac fibroblasts, a fetal factor in anti-SSA/Ro-SSB/La anti-body-mediated congenital heart block. J Immunol 2002; 169: 2156-63.
5. Boutjdir M. Molecular and ionic basis of congenital complete heart block. Trends Cardiavasc Med 2000; 10: 114-22.
6. Siren MK, Julkunen H, Kaaja R. The increasing incidence of isolated congenital heart block in Finland. J Rheumatol 1998; 25: 1862-4.
7. Buyon JP, Hiebert R, Copel J et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 1998; 31: 1658-66.
8. Cimaz R, Spence DL, Hornberger L, Silverman ED. Incidence and spectrum of neonatal lupus erythematosus: a prospective study in infants born to mothers with anti-Ro autoantibodies. J Pediatr 2003; 142: 678-83.
9. Brucato A, Frassi M, Franceschini F et al. Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. Arthritis Rheum 2001; 44: 1832-5.
10. Hunscher O, Batsita N, Rivero S et al. Clinical and serological identification of 2 forms of complete heart block in children. J Rheumatol 1995; 22: 1352-5.
11. Julkunen H, Miettinen A, Walle TK, Chan EK, Eronen M. Autoimmune response in mothers of children with congenital and pastnatally diagnosed isolated heart block: a population based study. J Rheumatol 2004; 31: 183-9.
12. Tseg CE, Di Donate F, Buyon JP. Stability of immunoblot profile of anti-SSA/Ro-SSB/La antibodies over time in mothers whose children have neonatal lupus. Lupus 1996; 5: 212-5.
13. Gregpratos G, Abrams J, Epstem AE et al. ACC/AHA/NASPE 2002 guidelines update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article. Circulation 2002; 106: 2145-61.
14. Batisse A, Dubeaux P, Fermont L, Kachaner J. Blocs auriculo- ventriculaires complets congénitaux. Arch Mal Cœur 1980; 73: 455-62.
15. Dewey RC, Capeless MA, Levy AM. Use of ambulatory électro- cardiographic monitoring to identify high risk patients with conqenital complete heart block. N Enql J Med 1987; 316: 835-9.
16. Karpawitch PP, Gillette PC, Garson A, Hesslein PS, Porter C, McNamara DG. Congenital complete atrioventricular block: clinical and electrophysiologic predictors of need for pacemaker insertion. Am J Cardiol 1981; 48: 1098-102.
17. Michaelsson M, Riesenfeld T, Jonzon A. Natural history of conqenital atrio-ventricular block. Pace 1997; 20: 2098-101.
18. Dodinot B, Marcon F, Mouna B, Ribeiro-Lages F, Godenir J, Pernot C. La stimulation cardiaque infantile. Expérience de vingt ans. Arch Mal Cœur 1988; 81: 673-83.
19. Cutler NG, Karpawich PP, Cavitt D, Hakimi M, Walters HL. Steroid-eluting epicardial pacing electrodes: six years experience of pacing thresholds in a growing pediatric population. PACE 1997; 20: 2943-8.
20. Villain E, Martelli H, Bonnet D, Iserin L, Butera G, Kachaner J. Characteristics and results of epicardial pacing in neonates and infants. PACE 2000; 23: 2052-6.
21. Friedman RA, Collins E, Fenrich AL. Pacing in children: indications and techniques. Progress in Pediat Cardiol 1995; 4: 21-9
22. Gillette PC, Zeigler VL, Winslow AT et al. Cardiac pacing in neonates, infants and preschool children. Pace 1992; 15: 2046-9.
23. Jaeggi ET, Hamilton RM, Silverman ED, Zamora SA, Hornberger LK. Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrio-ventricular block. J Am Coll cardiol 202; 39: 130-7.
24. Groves AMM, Allan LD, Rosental E. Outcome of isolated congenital complete heart block diagnosed in utero. Heart 1996; 75: 190-4.
25. Ing FF, Mullins CE, Grifka RG et al. Stent dilation of superior vena cava and inominate vein obstruction permits transvenous pacing lead implantation. PACE 1998; 21: 1517-30.
26. Dheedene M, Klug D, Jarwé M, Kouakam C, Marcjuie C, Kacet S. Infections secondaires à l'implantation d'un stimulateur cardiaque: mise au point. Ann Cardiol Angeiol 2000; 49: 230-7
27. Moak JP, Barron KS, Hougen TJ et al. Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela. J Am Coll Cardiol 2001; 37: 238-42.
28. Tatengco MV, Thomas RL, Karpawich PP. Left ventricular dysfunction after lonq term riqht ventricular pacing in the young. J Am Coll Cardiol 2001; 37: 2093-100.
29. Nield LE, Silverman ED, Taylor GP et al. Maternal anti-Ro and anti-la antibody-associated endocardial fibroelastosis. Circulation 2002; 105: 843-8.